iTeos Therapeutics, Inc. (ITOS) Ownership

$10.17

$0.01 (-0.1%)
Last update: 04:00 PM EST
Day's range
$10.14
Day's range
$10.31

iTeos Therapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BLACKROCK, INC. 05/02/2025 4.51 M $26.92 M   18.62% 10.43%
RA CAPITAL MANAGEMENT, L.P. 05/15/2025 3.65 M $21.78 M   74.41% 8.44%
BVF INC/IL 05/15/2025 3.08 M $18.36 M   32.26% 7.11%
MPM ASSET MANAGEMENT LLC 05/15/2025 2.74 M $16.35 B   0.00% 6.33%
TANG CAPITAL MANAGEMENT LLC 05/15/2025 2.69 M $16.05 M   1,112.90% 6.22%
JPMORGAN CHASE & CO 05/12/2025 1.98 M $11.84 M   -4.16% 4.59%
683 CAPITAL MANAGEMENT, LLC 05/15/2025 1.75 M $10.45 M   90.61% 4.05%
BIOIMPACT CAPITAL LLC 05/15/2025 1.75 M $10.42 M   0.00% 4.04%
VANGUARD GROUP INC 05/09/2025 1.73 M $10.31 M   5.66% 3.99%
DIMENSIONAL FUND ADVISORS LP 05/13/2025 1.18 M $7.05 M   -2.38% 2.73%
CITADEL ADVISORS LLC 05/15/2025 1.18 M $7.04 M   -17.63% 2.73%
VESTAL POINT CAPITAL, LP 05/15/2025 900.00 K $5.37 M   0.00% 2.08%
GEODE CAPITAL MANAGEMENT, LLC 05/13/2025 650.05 K $3.88 M   0.80% 1.50%
RENAISSANCE TECHNOLOGIES LLC 05/14/2025 645.60 K $3.85 M   -22.89% 1.49%
GOLDMAN SACHS GROUP INC 05/16/2025 587.42 K $3.51 M   -19.59% 1.36%
STATE STREET CORP 05/15/2025 582.00 K $3.47 M   -0.67% 1.35%
JACOBS LEVY EQUITY MANAGEMENT, INC 05/15/2025 557.94 K $3.33 M   -39.50% 1.29%
ACADIAN ASSET MANAGEMENT LLC 05/21/2025 536.79 K $3.20 M   14.17% 1.24%
CAPTION MANAGEMENT, LLC 05/15/2025 518.40 K $3.09 M   -31.83% 1.20%
MILLENNIUM MANAGEMENT LLC 05/15/2025 348.36 K $2.08 M   -15.26% 0.81%
05/12/2025 303.65 K $1.81 M   100.00% 0.70%
ALMITAS CAPITAL LLC 05/15/2025 275.12 K $1.64 B   0.00% 0.64%
MORGAN STANLEY 05/15/2025 251.13 K $1.50 M   0.21% 0.58%
NORTHERN TRUST CORP 05/13/2025 250.13 K $1.49 M   -3.70% 0.58%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/09/2025 233.56 K $1.39 M   17.25% 0.54%
AQR CAPITAL MANAGEMENT LLC 05/15/2025 226.21 K $1.35 M   88.59% 0.52%
EVERSEPT PARTNERS, LP 05/15/2025 220.20 K $1.31 M   0.00% 0.51%
DAFNA CAPITAL MANAGEMENT LLC 05/15/2025 213.35 K $1.27 M   13.27% 0.49%
AMERIPRISE FINANCIAL INC 05/14/2025 197.90 K $1.18 M   -3.55% 0.46%
TREXQUANT INVESTMENT LP 05/14/2025 188.50 K $1.13 M   4.74% 0.44%
BANK OF AMERICA CORP /DE/ 05/15/2025 180.10 K $1.08 M   193.66% 0.42%
KENNEDY CAPITAL MANAGEMENT LLC 05/13/2025 154.72 K $923.66 K   11.64% 0.36%
CAPTION MANAGEMENT, LLC 05/15/2025 154.49 K $922.32 K   -69.70% 0.36%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/14/2025 142.90 K $853.11 K   -86.68% 0.33%
WELLINGTON MANAGEMENT GROUP LLP 05/13/2025 140.12 K $836.51 K   27.00% 0.32%
04/30/2025 135.66 K $809.86 K   24.62% 0.31%
BARCLAYS PLC 05/15/2025 128.98 K $770.00 K   -2.95% 0.30%
K2 PRINCIPAL FUND, L.P. 05/15/2025 120.50 K $719.39 K   -34.69% 0.28%
MARSHALL WACE, LLP 05/15/2025 119.56 K $713.76 K   100.00% 0.28%
CUBIST SYSTEMATIC STRATEGIES, LLC 05/15/2025 112.09 K $669.19 K   80.28% 0.26%
STONEPINE CAPITAL MANAGEMENT, LLC 05/14/2025 110.00 K $656.70 K   0.00% 0.25%
QUBE RESEARCH & TECHNOLOGIES LTD 05/15/2025 107.76 K $643.35 K   -44.72% 0.25%
D. E. SHAW & CO., INC. 05/15/2025 104.13 K $621.63 K   84.18% 0.24%
VICTORY CAPITAL MANAGEMENT INC 05/02/2025 102.19 K $610.06 K   0.42% 0.24%
ADAR1 CAPITAL MANAGEMENT, LLC 05/15/2025 101.10 K $603.54 K   -23.18% 0.23%
INVESCO LTD. 05/12/2025 85.20 K $508.66 K   0.90% 0.20%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 05/14/2025 84.50 K $504.48 K   100.00% 0.20%
ALGERT GLOBAL LLC 05/13/2025 79.95 K $477.00 K   15.02% 0.18%
IKARIAN CAPITAL, LLC 05/15/2025 78.59 K $469.15 K   0.00% 0.18%
HSBC HOLDINGS PLC 05/14/2025 76.99 K $458.49 K   62.41% 0.18%

iTeos Therapeutics, Inc. institutional Ownership - FAQ's

During the previous two years, 166 institutional investors and hedge funds held shares of iTeos Therapeutics, Inc.. The most heavily invested institutionals were:

BlackRock, Inc.: 4.51 M

RA CAPITAL MANAGEMENT, L.P.: 3.65 M

BVF INC/IL: 3.08 M

MPM ASSET MANAGEMENT LLC: 2.74 M

TANG CAPITAL MANAGEMENT LLC: 2.69 M

JPMORGAN CHASE & CO: 1.98 M

85.49% of iTeos Therapeutics, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 43.89 M shares in the last 24 months. This purchase volume represents approximately $446.34 M in transactions.